PMLRARA Quantitative Single form Test
At DNA Labs UAE, we offer the PMLRARA Quantitative Single form Test for AED 1520.0. This test measures the amount of PMLRARA fusion gene in a patient’s blood or bone marrow sample.
Test Details
The PMLRARA quantitative test is used to diagnose acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). It measures the fusion gene formed by the PML and RARA genes. This fusion gene is crucial in the development of APL and serves as a diagnostic marker for the disease.
The test is performed using real-time polymerase chain reaction (PCR), which amplifies and quantifies the amount of PMLRARA fusion gene present in the sample. The results are reported as a numerical value, indicating the level of PMLRARA in the patient’s blood or bone marrow.
Symptoms and Diagnosis
Patients with APL may experience symptoms such as easy bruising, bleeding, fatigue, and frequent infections. A diagnosis of APL is typically made through a combination of physical examinations, blood tests, and bone marrow biopsies.
Referring Details
To undergo the PMLRARA Quantitative Single form Test, a doctor’s prescription is required. However, prescriptions are not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Report Delivery
After the test, the report will be delivered within 2-3 days.
Test Department
This test falls under the genetics department at DNA Labs UAE.
Pre Test Information
PMLRARA Quantitative Single form Test can be done with a doctor’s prescription. However, it is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Conclusion
The PMLRARA Quantitative Single form Test is an essential tool in the management of APL patients. It helps guide treatment decisions and monitor disease progression, allowing healthcare providers to tailor treatment plans and optimize outcomes.
Test Name | PMLRARA Quantitative Single form Test |
---|---|
Components | EDTA Vacutainer (4ml) |
Price | 1520.0 AED |
Sample Condition | Bone marrow \/ Peripheral blood (Transport immediately) |
Report Delivery | 2-3 days |
Method | Real Time PCR |
Test type | Genetics |
Doctor | General Physician |
Test Department: | |
Pre Test Information | PML/RARA Quantitative Single form] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
PML/RARA quantitative refers to a laboratory test that measures the amount of PML/RARA fusion gene in a patient’s blood or bone marrow sample. PML/RARA is a genetic abnormality commonly found in patients with acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). The PML/RARA fusion gene is formed when parts of two separate genes, PML and RARA, fuse together. This fusion gene plays a crucial role in the development of APL and is used as a diagnostic marker for this disease. The quantitative measurement of PML/RARA is important for monitoring the response to treatment and assessing the risk of relapse in APL patients. A decrease in the level of PML/RARA during treatment indicates a good response, while an increase or persistence of the fusion gene suggests a higher risk of relapse. The test is typically performed using a technique called real-time polymerase chain reaction (PCR), which amplifies and quantifies the amount of PML/RARA fusion gene present in the sample. The results are reported as a numerical value, representing the level of PML/RARA in the patient’s blood or bone marrow. The PML/RARA quantitative test is an important tool in the management of APL patients, as it helps guide treatment decisions and monitor disease progression. It allows healthcare providers to tailor treatment plans to individual patients and optimize their outcomes. |